(Q46021985)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18073777%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Drug safety in pregnant women and their babies: ignorance not bliss (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18073777%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18073777%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Chambers CD

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18073777%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Polifka JE

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18073777%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

12 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18073777%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18073777%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18073777%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18073777%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

181-183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18073777%20AND%20SRC:MED&resulttype=core&format=json

Prescription drug use in pregnancy.

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

Unintended Pregnancy in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

Alcohol use prior to pregnancy recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

Communicating risks during pregnancy: a workshop on the use of data from animal developmental toxicity studies in pregnancy labels for drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

Risks, values, and decision making surrounding pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

Teratogenicity of recently introduced medications in human pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

7 January 2021

Systematic Identification of Drugs That Cause Birth Defects — A New Opportunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

7 January 2021

Birth outcomes in pregnant women taking fluoxetine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

7 January 2021

Perinatal risks of untreated depression during pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

7 January 2021

FDA classification of drugs for teratogenic risk: Teratology society public affairs committee

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

7 January 2021

Teratology public affairs committee position paper: Pregnancy labeling for prescription drugs: Ten years later

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

7 January 2021

Use of antidepressants by pregnant women: evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

7 January 2021

Prevention of unnecessary pregnancy terminations by counselling women on drug, chemical, and radiation exposure during the first trimester

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

7 January 2021

Problems with informing women adequately about teratogen risk: some barriers to preventing exposures to known teratogens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100448

7 January 2021